Cargando…

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022

Detalles Bibliográficos
Autores principales:	Link-Gelles, Ruth, Ciesla, Allison Avrich, Fleming-Dutra, Katherine E., Smith, Zachary R., Britton, Amadea, Wiegand, Ryan E., Miller, Joseph D., Accorsi, Emma K., Schrag, Stephanie J., Verani, Jennifer R., Shang, Nong, Derado, Gordana, Pilishvili, Tamara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2022
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721148/ https://www.ncbi.nlm.nih.gov/pubmed/36454688 http://dx.doi.org/10.15585/mmwr.mm7148e1

Ejemplares similares

Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3–5 Years — Increasing Community Access to Testing Program, United States, July 2022–February 2023
por: Fleming-Dutra, Katherine E., et al.
Publicado: (2023)

Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023
por: Link-Gelles, Ruth, et al.
Publicado: (2023)

Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron
por: Accorsi, Emma K., et al.
Publicado: (2022)

Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023
por: Moulia, Danielle L., et al.
Publicado: (2023)

Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021
por: Nanduri, Srinivas, et al.
Publicado: (2021)

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022
por: Rosenblum, Hannah G., et al.
Publicado: (2022)

Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022
por: Prasad, Namrata, et al.
Publicado: (2022)

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022
por: Tenforde, Mark W., et al.
Publicado: (2022)

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022
por: Tenforde, Mark W., et al.
Publicado: (2023)

Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021
por: Britton, Amadea, et al.
Publicado: (2021)

Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months–5 Years — VISION Network, United States, July 2022–June 2023
por: Link-Gelles, Ruth, et al.
Publicado: (2023)

2365. Effectiveness of COVID-19 Vaccines Against Medically Attended COVID-19 in Pregnant Persons Within the VISION Network, December 2021 - April 2023
por: Ciesla, Allison Avrich, et al.
Publicado: (2023)

2082. Effectiveness of Bivalent mRNA Vaccines in Preventing SARS-CoV-2 Infection Among Children Aged 5-17 years: an Evaluation of Multicenter Prospective Cohorts, United States, September 2022 - January 2023
por: Feldstein, Leora R, et al.
Publicado: (2023)

Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023
por: Link-Gelles, Ruth, et al.
Publicado: (2023)

Indian Regulatory Update: September-November 2013
por: Suvarnapathaki, Kedar
Publicado: (2014)

Avian influenza overview September – November 2017
por: Brown, Ian, et al.
Publicado: (2017)

Systematic Review and Meta-Analysis of the Efficacy and Effectiveness of Pneumococcal Vaccines in Adults
por: Farrar, Jennifer L., et al.
Publicado: (2023)

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022
por: Surie, Diya, et al.
Publicado: (2022)

Pediatric Brain Abscesses, Epidural Empyemas, and Subdural Empyemas Associated with Streptococcus Species — United States, January 2016–August 2022
por: Accorsi, Emma K., et al.
Publicado: (2022)

Tularemia in Children, Turkey, September 2009–November 2012
por: Tezer, Hasan, et al.
Publicado: (2015)

Meteorological Register: From September 1 to November 30
Publicado: (1834)

Meteorological Register: From September 1 to November 30
Publicado: (1835)

Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults — United States, November 1–December 10, 2022
por: Sinclair, Alyssa H., et al.
Publicado: (2023)

Correction and Republication: Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022
Publicado: (2023)

Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022
por: Huiberts, Anne J, et al.
Publicado: (2023)

August Krogh : November 15, 1874—September 13, 1949
por: Rehberg, P. Brandt
Publicado: (1951)

COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults — United States, November–December 2022
por: Lu, Peng-jun, et al.
Publicado: (2023)

Effectiveness of bivalent COVID-19 boosters against COVID-19 mortality in people aged 65 years and older, Australia, November 2022 to May 2023
por: Liu, Bette, et al.
Publicado: (2023)

Acute Flaccid Myelitis Among Children — Washington, September–November 2016
por: Bonwitt, Jesse, et al.
Publicado: (2017)

Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021–September 2022
por: Foulkes, Sarah, et al.
Publicado: (2023)

23. Regional Variation in Outpatient Antibiotic Prescribing in a Commercially-insured Population, United States, 2017
por: Bizune, Destani J, et al.
Publicado: (2020)

Regional Variation in Outpatient Antibiotic Prescribing for Acute Respiratory Tract Infections in a Commercially Insured Population, United States, 2017
por: Bizune, Destani, et al.
Publicado: (2023)

In the literature: November 2022
por: Gambardella, V., et al.
Publicado: (2022)

Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
por: Kobayashi, Miwako, et al.
Publicado: (2022)

SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine — Ohio and Rhode Island, September–November 2022
por: Canaday, David H., et al.
Publicado: (2023)

In the Limelight: September 2022
por: Nath, Karl A.
Publicado: (2022)

20th November 1986, 18th September 1986 3 July 1986
por: Minutes of SCOOP Meetings
Publicado: (1987)

PS Coordination memorandum: Bi-monthly Schedule PS, 25 September - 18 November
por: Von Dardel, G
Publicado: (1961)

SC status report 12th September 1977 to 30th November 1977
por: Standley, P H
Publicado: (1977)

Ebola Virus Outbreak Investigation, Sierra Leone, September 28–November 11, 2014
por: Lu, Hui-Jun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_66hjnc6ehsp8vqadji3lrr59mo